Creatine Kinase MB (CK-MB)
What is analysed?
Creatine Kinase MB (CK-MB) is an enzyme primarily found in the heart muscle. The CK-MB test measures enzyme levels in the blood, assessing and monitoring cardiac health with a focus on potential heart muscle damage.
What does the result mean?
Elevated CK-MB levels may indicate heart muscle damage, such as during a heart attack or other cardiac events.
Why is the analysis necessary?
The analysis of CK-MB is crucial for diagnosing and managing heart-related conditions. It helps healthcare professionals identify potential cardiac issues and formulate appropriate treatment plans.
When should the analysis be conducted?
The CK-MB analysis is typically ordered in emergency situations where there is suspicion of a heart attack and for routine monitoring in patients with known heart conditions.
What sample is required?
A blood sample is required for CK-MB analysis, obtained through a standard blood draw, and sent to a laboratory for testing. No specific preparation is usually required, but informing healthcare providers about medications or supplements is essential.
How is it used?
The CK-MB test is used alongside other cardiac markers to provide a comprehensive assessment of heart health. It aids in diagnosing heart attacks and determining the extent of cardiac muscle damage.
What are the normal values?
CK-MB Level |
Interpretation |
0-3% |
Normal |
4-6% |
Borderline |
>6% |
Elevated (indicative of risk) |
What does it indicate to have altered values?
Elevated CK-MB levels suggest potential heart muscle damage, confirming the diagnosis of a heart attack or indicating other cardiac conditions that require further investigation and management.